Skip to main content
. 2016 May 16;6:25679. doi: 10.1038/srep25679

Figure 4. Cathelicidin-WA ameliorated LPS-induced inflammation via TLR4- and MyD88-dependent signaling pathways.

Figure 4

(A) The effects of CWA and Enro on IL-6 expression in LPS-induced macrophages. (B) The effects of CWA on LPS-induced IL-6 expression in TLR4- and MyD88-silenced macrophages. All data are expressed as the mean ± SEM (n = 6). Differences were determined by one-way ANOVA. Enro, Enrofloxacin; CWA, Cathelicidin-WA. *P < 0.05 compared with LPS; NS, not significant, P > 0.05.